Prognostic nomogram models for elderly patients with differentiated thyroid carcinoma: A population-based study

Dasong Wang,Yan Yang,Hongwei Yang,Yu He,Zhengyan Wang,Maoshan Chen,Yunhui Huang,Lei Yang

DOI: https://doi.org/10.1097/md.0000000000040381

IF: 1.6

2024-11-06

Medicine

Abstract:Thyroid cancer is the most common endocrine malignancy, accounting for approximately 3% of all cancers. [ 1 ] The incidence of thyroid cancer has been steadily increasing over the past few decades. [ 2 , 3 ] The majority of thyroid cancer cases are classified as differentiated thyroid carcinoma (DTC), including papillary and follicular thyroid carcinoma. [ 4–6 ] The incidence of DTC is higher in females than males and increases with age, with more than half of the cases occurring in patients over the age of 55. [ 7 , 8 ] It is generally a curable cancer, with a 10-year survival rate of approximately 90%. [ 9 ] However, the prognosis of DTC in elderly patients is a concern due to the higher prevalence of comorbidities and reduced life expectancy. [ 10 , 11 ] Elderly patients with DTC often present with more advanced disease and have a higher risk of mortality compared to younger patients. [ 11 , 12 ] This is partly due to the fact that older patients may have preexisting comorbidities that can complicate the management of their thyroid cancer. [ 6 , 13 , 14 ] Several studies have investigated the impact of age on the cause of death in patients with DTC. [ 12 , 13 , 15 ] A study conducted by Haymart et al found that while most patients with DTC died from other causes, older patients were more likely to die from tumor-specific causes compared to younger patients. [ 15 ] This suggests that tumor-specific mortality may become more significant as patients age.

medicine, general & internal